Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial.
Zhou Y, Liu Y, Jiang L, Zhang R, Zhang H, Shi Q, Yang Z, Mao Y, Liu S, Yang Z, Ding J, Zhou Y, Ren B, He L, Zhao X, Li W, Li S, Liu D.
Zhou Y, et al. Among authors: liu y, liu s, liu d.
J Med Virol. 2023 Dec;95(12):e29318. doi: 10.1002/jmv.29318.
J Med Virol. 2023.
PMID: 38112106